<p>In (A), the levels of Th1/Th17-associated cytokines were assessed at day 4 post-infection via QPCR of lung RNA. In (B), the levels of CXCL9 and CXCL10 were assessed at day 4 post-infection via Bioplex multiplex assay of lung homogenates. Each column represents 5 mice per group, and the experiment was repeated with similar results. * = p<0.05.</p
<p>Wild-type or CD1d KO neonatal mice were i.n. administered PBS, α-GC, RSV, or α-GC+ RSV and challe...
<p>After RSV B (KR/B/10-12) challenge, all mice (n = 4/group) were sacrificed and lung mononuclear c...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
<p>Mice were vaccinated with NE-RSV or FI-RSV, as described, and challenged with live RSV. In (A), t...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>Mice were vaccinated with NE-RSV as described. Control and vaccinated mice were challenged at day...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were vaccinated with 50 µg of RSV G nanoparticles, 10 µg of purified G protein emulsified 1:...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). Where indicated, mice were in...
<p>Mice (n = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>(A) Eight days after RSV infection, airway responses were measured in control (cont), RSV-infecte...
Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characteriz...
<p>(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two ...
Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characteriz...
<p>Wild-type or CD1d KO neonatal mice were i.n. administered PBS, α-GC, RSV, or α-GC+ RSV and challe...
<p>After RSV B (KR/B/10-12) challenge, all mice (n = 4/group) were sacrificed and lung mononuclear c...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...
<p>Mice were vaccinated with NE-RSV or FI-RSV, as described, and challenged with live RSV. In (A), t...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>Mice were vaccinated with NE-RSV as described. Control and vaccinated mice were challenged at day...
<p>Immunized mice were vaccinated intranasally (i.n.) twice at day 0 and day 28 with NE-RSV (10<sup>...
<p>BALB/c mice and IL-10<sup>−/−</sup> mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). ...
<p>Mice were vaccinated with 50 µg of RSV G nanoparticles, 10 µg of purified G protein emulsified 1:...
<p>BALB/c mice were infected with 10<sup>6</sup> PFU RSV i.n. (day 0). Where indicated, mice were in...
<p>Mice (n = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>(A) Eight days after RSV infection, airway responses were measured in control (cont), RSV-infecte...
Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characteriz...
<p>(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two ...
Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characteriz...
<p>Wild-type or CD1d KO neonatal mice were i.n. administered PBS, α-GC, RSV, or α-GC+ RSV and challe...
<p>After RSV B (KR/B/10-12) challenge, all mice (n = 4/group) were sacrificed and lung mononuclear c...
<p>RSV-infected mice were treated with suboptimal doses of either anti-G mAb (130-6D, 150 µg/mouse) ...